SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Privi Speciality Chemicals Ltd (PRIVISCL)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 530117 NSE: PRIVISCL Chemicals | Small Cap | Privi Speciality Che Share Price

₹3,255.95 3.25 (0.10%)

As on 04-Jun'26 16:59

Privi Speciality Chemicals Ltd (PRIVISCL)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 530117 NSE: PRIVISCL Chemicals | Small Cap | Privi Speciality Che Share Price

₹3,255.95 3.25 (0.10%)

As on 04-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹12,719 Cr.
Current Price
₹3,256
52-Week Low / High
₹2,050 / 3,595
TTM EPS
₹91.5
TTM Sales
₹2,456 Cr.
Book Value per Share
₹368
P/E Ratio
35.58
Lower than its 5-year historical median
Industry PE
50.2
Price to Book (P/B)
8.85
Higher than its 5-year historical median
Price to Sales (P/S)
5.18
Higher than its 5-year historical median
EV/EBITDA
19.84
Lower than its 5-year historical median
Dividend Yield
0.29%
Profitability Efficiency
Return on Equity (ROE)
18.73%
Outperforms industry median
Return on Capital Employed (ROCE)
18.09%
Outperforms industry median
Return on Assets (ROA)
8.12%
Operating Profit Margin
22%
Net Profit Margin
9.29%
Gross Profit Margin
18.7%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
19.06%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
36.23%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
93.4%
Asset Quality
Promoter Holding
60.60%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹1,399 Cr.
Equity
₹39.1 Cr.
Face Value
₹10
All Time Low / High
₹1.24 / 3594.85

Privi Speciality Chemicals stock performance

Key Ratios
mw4me loader

Check Before You Invest

Quality

Somewhat Good

Valuation

Fair

Price Trend

Semi Strong
Q.1 Is Privi Speciality Chemicals Ltd a good quality company?
Privi Speciality Chemicals Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Privi Speciality Chemicals Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Privi Speciality Chemicals Ltd vs industry peers?
Privi Speciality Chemicals Ltd revenue CAGR is 9.50%, compared to the industry median CAGR of 7.53%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Privi Speciality Chemicals Ltd?
Promoters hold 60.60% of the Privi Speciality Chemicals Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Privi Speciality Chemicals Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 28.3% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Privi Speciality Chemicals Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 22.4%17.2%22.2%22.4%36.2%15.7%11.1%5.6%12.5%18.1%-
Value Creation
Index
0.60.20.60.61.60.1-0.2-0.6-0.10.3-

Growth Parameters

Sales 1521852362501,2951,2551,3911,5781,7122,0382,456
Sales YoY Gr.-22.2%27.5%5.7%418.1%-3.1%10.9%13.4%8.5%19.1%-
Adj EPS 7.92.45.25.626.122.519.82.621.746.391.5
YoY Gr.--69.3%113.6%8.1%367.1%-13.9%-12%-86.9%735.8%112.9%-
BVPS (₹) 45.918.822.826.3154.3182.8206.7210.6235.6281.9368
Adj Net
Profit
10.99.119.521.810287.977.310.284.9181357
Cash Flow from Ops. 15.73.815.534.221615214.854.7362304-
Debt/CF from Ops. 2.115.44.21.72.23.459.518.72.42.8-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales 33.5%9.5%13.6%19.1%
Adj EPS 21.7%12.1%32.7%112.9%
BVPS22.4%12.8%10.9%19.6%
Share Price 27.4% 25.6% 41.5% 26.8%

Key Financial Parameters

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
18.113.524.42328.913.310.21.39.717.928.2
Op. Profit
Mgn %
15.412.814.314.616.616.514.111.619.22226.8
Net Profit
Mgn %
7.24.98.28.77.975.60.658.914.6
Debt to
Equity
0.50.80.80.60.80.71.11.310.80.2
Working Cap
Days
78839510310019822825624321597
Cash Conv.
Cycle
566171785510011414915013524

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales1521852362501,2951,2551,3911,5781,7122,038
Operating Expenses + 1291622032141,0801,0481,1951,3951,3831,590
Manufacturing Costs17192326146158192248237264
Material Costs981221571637757268059289611,074
Employee Cost 8111315606368726575
Other Costs 61099100101129146120177
Operating Profit 23243436215207197183329448
Operating Profit Margin (%) 14.9%12.8%14.3%14.4%16.6%16.5%14.1%11.6%19.2%22.0%
Other Income + 1034262033222218
Exceptional Items 000040235000
Interest 4566372325689785
Depreciation 3455556973105122127
Profit Before Tax 1715262918915813731132254
Tax 666845413593465
Profit After Tax 11919221441171022298189
PAT Margin (%) 7.0%4.9%8.2%8.6%11.1%9.3%7.3%1.4%5.7%9.3%
Adjusted EPS (₹)7.72.45.25.536.930.026.05.825.148.5
Dividend Payout Ratio (%)32.50%41.50%29.10%45.40%4.10%6.70%7.70%0%8%10.30%

Valuation of Privi Speciality Che - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 6372871036037148078229201,101
Share Capital 14393939393939393939
Reserves 493348645646757687838811,062
Debt +29505549462474816922747711
Long Term Debt1219168226332381404384279
Short Term Debt17323940237142435518364431
Minority Interest0000000000
Trade Payables36710157180308298283405
Others Liabilities 20252727142154197301238257
Total Liabilities 1141541761881,3641,5222,1282,3432,1892,473

Fixed Assets

Net Fixed Assets +7394102115564565666982999979
Gross Block102981111308519211,0931,5131,6491,754
Accumulated Depreciation294914287356427532650775
CWIP 533130174370932770
Investments 0000434351516262
Inventories13233034308315561745603723
Trade Receivables17253232217236284314361401
Cash Equivalents 0000851531142041
Others Assets 5896117173166143117198
Total Assets 1141541761881,3641,5222,1282,3432,1892,473

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 16415342161521555362304
PBT 1715262918915813731132254
Adjustment 89887610397181210229
Changes in Working Capital -5-15-13115-70-187-14546-109
Tax Paid -3-5-5-5-65-39-32-13-26-70
Cash Flow From Investing Activity + -13-20-13-14-174-242-324-141-118-144
Capex -13-20-15-17-170-242-316-142-103-148
Net Investments 0-00-0-4-0-01-54
Others 003410-70-100
Cash Flow From Financing Activity + -317-3-21291932470-239-135
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 011-1-1056120766414-108
Interest Paid -4-5-6-6-35-22-34-65-92-82
Dividend Paid -3-4-4-60-6-8-80-8
Others 415728-7329078-16163
Net Cash Flow -00-0-072-7115-16525

Financial Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)17.6613.5424.822.8340.8317.7713.372.7611.2318.73
ROCE (%)22.4417.1522.2422.3836.2415.6511.125.6312.5218.09
Asset Turnover Ratio1.521.521.481.381.670.870.760.710.760.87
PAT to CFO Conversion(x)1.450.440.791.551.51.30.152.53.691.61
Working Capital Days
Receivable Days3838.2042.8046.5035.1065.8068.2069.207268.20
Inventory Days29.2032.7039.9046.7048.1090.40114.80151.10143.70118.70
Payable Days14.3013.2015.6019.5039.4084.90110.70119.1096.9081.20

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Privi Speciality Chemicals Ltd FAQs

The current trading price of Privi Speciality Che on 04-Jun-2026 16:59 is ₹3,256.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Privi Speciality Che stood at ₹12,718.6 Cr

The latest P/E ratio of Privi Speciality Che as of 03-Jun-2026 is 35.58.

The latest P/B ratio of Privi Speciality Che as of 03-Jun-2026 is 8.85.

The 52-week high of Privi Speciality Che is ₹3,594.9 and the 52-week low is ₹2,050.4.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Privi Speciality Che is ₹2,456 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Privi Speciality Chemicals Ltd is a average quality company.

The key valuation ratios of Privi Speciality Chemicals Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Privi Speciality Chemicals Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About Privi Speciality Chemicals Ltd

H. K. Finechem is a manufacturing company located near the city of Ahmedabad in the western region of India. Their company utilizes state of the art technology with critical equipments acquired from Germany and Switzerland. Fractions of natural oils and fats such as soyabean, sunflower and cottonseed are the source of the company's fine chemical products. They specialize in oleo chemicals and products for the nutraceutical industry. Their hallmark has been consistent supply of products of superior quality in India, USA, Europe and Japan.

H. K. Finechem is a technology driven company. It has faced the challenges successfully to commercialize products which would help customers in increasing efficiency, reducing cost and minimizing environmental impact. 

Their products are manufactured and marketed in a safe and socially acceptable manner by meeting legal obligations.

The company continuously strive to improve quality which is achieved with the help of a  sophisticated laboratory having the latest analytical equipments manned by experienced and dedicated personnel. It successfully manufactures quality products developed in-house for the first time in India using high vacuum technology in our modern manufacturing facility.

Product range of the company includes:

The Company's principal activity is to manufacture speciality oleo chemicals and products for the nutraceutical industry. The Company's main products are mixed tocopherols, sterols, linoleic acid, monobasic acid and dimer acid for polyamides and printing ink industry. It processes both the by product streams of vegetable oil refineries viz. vegetable oil based fatty acid distillate and acid oil.

OLEO Chemicals

  • Dimer Fatty Acid
  • Monomer Fatty Acid
  • Linoleic Fatty Acid
  • Soya Fatty Acid
  • Saturated Fatty Acid
  • Distilled Fatty Acid
  • Glycerine
  • Oil for Industrial Purpose

Intermediate Nutraceutical & Health Products

  • Natural Concentrated Tocopherols
  • Natural Concentratred Sterols
You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×